Literature DB >> 9099667

Phosphorylation of glial fibrillary acidic protein at the same sites by cleavage furrow kinase and Rho-associated kinase.

H Kosako1, M Amano, M Yanagida, K Tanabe, Y Nishi, K Kaibuchi, M Inagaki.   

Abstract

Site- and phosphorylation state-specific antibodies are useful to analyze spatiotemporal distribution of site-specific phosphorylation of target proteins in vivo. Using several polyclonal and monoclonal antibodies that can specifically recognize four phosphorylated sites on glial fibrillary acidic protein (GFAP), we have previously reported that Thr-7, Ser-13, and Ser-34 on this intermediate filament protein are phosphorylated at the cleavage furrow during cytokinesis. This observation suggests that there exists a protein kinase named cleavage furrow kinase specifically activated at metaphase-anaphase transition (Matsuoka, Y., Nishizawa, K., Yano, T., Shibata, M., Ando, S., Takahashi, T., and Inagaki, M. (1992) EMBO J. 11, 2895-2902; Sekimata, M., Tsujimura, K., Tanaka, J., Takeuchi, Y., Inagaki, N., and Inagaki, M. (1996) J. Cell Biol. 132, 635-641). Here we report that GFAP is phosphorylated specifically at Thr-7, Ser-13, and Ser-34 by Rho-associated kinase (Rho-kinase), which binds to the small GTPase Rho in its GTP-bound active form. The kinase activity of Rho-kinase toward GFAP is dramatically stimulated by guanosine 5'-(3-O-thio)-triphosphate-bound RhoA. Furthermore, the phosphorylation of GFAP by Rho-kinase results in a nearly complete inhibition of its filament formation in vitro. The possibility that Rho-kinase is a candidate for cleavage furrow kinase is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9099667     DOI: 10.1074/jbc.272.16.10333

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

2.  Association of Pasteurella multocida toxin with vimentin.

Authors:  Hiroaki Shime; Takahiro Ohnishi; Kaori Nagao; Kiyomasa Oka; Toshifumi Takao; Yasuhiko Horiguchi
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 3.  PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.

Authors:  Zhou-shen Zhao; Ed Manser
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 4.  Desmin cytoskeleton in healthy and failing heart.

Authors:  Y Capetanaki
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

Review 5.  ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases.

Authors:  André Schmandke; Antonio Schmandke; Stephen M Strittmatter
Journal:  Neuroscientist       Date:  2007-10       Impact factor: 7.519

Review 6.  Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments.

Authors:  Ram K Sihag; Masaki Inagaki; Tomoya Yamaguchi; Thomas B Shea; Harish C Pant
Journal:  Exp Cell Res       Date:  2007-04-12       Impact factor: 3.905

7.  Protective role of phosphorylation in turnover of glial fibrillary acidic protein in mice.

Authors:  Masaaki Takemura; Hiroshi Gomi; Emma Colucci-Guyon; Shigeyoshi Itohara
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

8.  Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice.

Authors:  Woosung Cho; Albee Messing
Journal:  Exp Cell Res       Date:  2008-12-29       Impact factor: 3.905

9.  Suppression of glial tumor growth by expression of glial fibrillary acidic protein.

Authors:  M Toda; M Miura; H Asou; I Sugiyama; T Kawase; K Uyemura
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

10.  Expression of tryptophan 2,3-dioxygenase in mature granule cells of the adult mouse dentate gyrus.

Authors:  Koji Ohira; Hideo Hagihara; Keiko Toyama; Keizo Takao; Masaaki Kanai; Hiroshi Funakoshi; Toshikazu Nakamura; Tsuyoshi Miyakawa
Journal:  Mol Brain       Date:  2010-09-05       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.